IP Library Granted Patent US 8,153,739
Granted Patent B2
US 8,153,739 · App. 12/795,892 · Granted Apr 10, 2012

Antimicrobial polymers

Assignee: University of Massachusetts
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,153,739
App. No.
12/795,892
Granted
Apr 10, 2012
Kind
B2
Abstract

The invention generally relates to novel polymers (SMAMPs) and their syntheses and use. The polymers exhibit promising properties of AMPs. In particularly, for example, a ring-opening metathesis polymerization (ROMP) platform was developed that allows syntheses of SMAMPs that employ a minimum number of norbornene-based building blocks and/or enable easy and independent variation of hydrophobic and hydrophilic groups in the monomer units and/or along the polymeric backbone to finetune and select desirable properties of the polymers.

Claims (45)

1. A monomer unit having the structure of:

wherein one of R 1 and R 2 comprises a hydrophobic group and the other one of R 1 and R 2 comprises a hydrophilic group; and X is C═R 3 , O or S, wherein R 3 is a C 1 -C 12 alkyl or alkoxy group.

2. The monomer of claim 1 , wherein the hydrophobic group comprises a substituted or unsubstituted alkyl group.

3. The monomer of claim 1 , wherein the hydrophilic group comprises a group selected from ammonium ions, sulfonium ions, guanidinium ions, phosphonium ions, and mono- and di-alkyl substituted amino groups.

4. The monomer of claim 1 , wherein X is O; R 1 is a linear or branched C 1 -C 12 alkyl group; and R 2 is

or a guanidinium ion wherein p is an integer from 1-10.

5. The monomer of claim 1 , wherein both —C(═O)O— groups in (I) occupy the exo-stereo position.

6. The monomer of claim 4 , wherein R 1 is a linear or branched C 1 -C 6 alkyl group; and

p is an integer from 1-5.

7. The monomer of claim 1 , wherein X is C═R 3 ; R 1 is a linear or branched C 1 -C 12 alkyl group; and R 2 is

or a guanidinium ion, wherein p is an integer from 1-10.

8. The monomer of claim 7 , wherein R 3 is a C 1 -C 12 alkyl.

9. A polymer comprising a monomer unit having the structure of:

wherein one of R 1 and R 2 comprises a hydrophobic group and the other one of R 1 and R 2 comprises a hydrophilic group; and X is C═R 3 , O or S, wherein R 3 is a C 1 -C 12 alkyl or alkoxy group.

10. The polymer of claim 9 , wherein the hydrophobic group comprises a substituted or unsubstituted alkyl group.

11. The polymer of claim 9 , wherein the hydrophilic group comprises a group selected from ammonium ions, sulfonium ions, guanidinium ions, phosphonium ions, and mono- and di-alkyl substituted amino groups.

12. The polymer of claim 9 , wherein X is O; R 1 is a linear or branched C 1 -C 12 alkyl group; and R 2 is

or a guanidinium ion, wherein p is an integer from 1-10.

13. The polymer of claim 9 , wherein both —C(═O)O— groups in (II) occupy the exo-stereo position.

14. The polymer of claim 12 , wherein R 1 is a linear or branched C 1 -C 6 alkyl group; and

p is an integer from 1-5.

15. The polymer of claim 9 , wherein X is C═R 3 ; R 1 is a linear or branched C 1 -C 12 alkyl group; R 2 is

or a guanidinium ion, wherein p is an integer from 1-10.

16. The polymer of claim 15 , wherein R 3 is a C 1 -C 12 alkyl.

17. The polymer of claim 9 , wherein n is an integer from about 1 to about 1,000.

18. The polymer of claim 9 , wherein the polymer is a co-polymer.

19. The co-polymer of claim 18 , wherein the co-polymer comprises the structural monomer units of:

wherein

each of X′ and X″ is C═R 3 , O or S, wherein R 3 is a C 1 -C 12 alkyl or alkoxy group;

each of R 1 ′ and R 1 ″ is a hydrophobic group and each of R 2 ′ and R 2 ″ is a hydrophilic group, provided that R 1 ′ and R 1 ″ are not the same, R 2 ′ and R 2 ″ are the same, or X′ and X″ are not the same; and

each of m and n is an integer from about 1 to about 1,000.

20. The polymer of claim 19 , wherein the hydrophilic group comprises a group selected from ammonium ions, sulfonium ions, guanidinium ions, phosphonium ions, and mono- and di-alkyl substituted amino groups.

21. The polymer of claim 19 , wherein all —C(═O)O— groups in (III) and (IV) occupy the exo-stereo position.

22. The co-polymer of claim 19 , wherein

each of R 1 ′ and R 1 ″ is independently a linear or branched C 1 -C 12 alkyl group; and

each of R 2 ′ and R 2 ″ is independently

or a guanidinium ion, wherein p is an integer from 1-10.

23. A polymer prepared by ring-opening metathesis polymerization, the polymer comprising hydrophobic and hydrophilic groups attached to the polymeric backbone such that, within a monomeric structural unit, the hydrophobic and hydrophilic groups are attached to the polymeric backbond at adjacent atoms.

24. The polymer of claim 23 , wherein the hydrophobic and hydrophilic groups are attached to the polymeric backbond via ester linkages.

25. The polymer of claim 23 , wherein the

hydrophobic group comprises a linear or branched C 1 -C 12 alkyl group; and

the hydrophilic group comprises a —NH 3 + group.

26. The polymer of claim 25 , wherein the hydrophilic group comprises

or a guanidinium ion, wherein p is an integer from 1-10.

27. The polymer of claim 23 , wherein the polymer is a co-polymer.

Assignments (1)
INTELLECTUAL PROPERTY SECURITY AGREEMENT RELATING TO PATENTS LICENSED BY POLYMEDIX PHARMACEUTICALS, INC. OR POLYMEDIX, INC. Recorded Jan 17, 2013
From: POLYMEDIX, INC.; POLYMEDIX PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL SBIC, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 029660/0282 →
Continuity (2)
Provisional Application 61185035 · Jun 8, 2009
Related Publication 20100317870A1 · Dec 16, 2010